Skip to main content

Closed

CLDX: Celldex Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+2.0% / yr

Operating margin-37694.6%

ROIC-67.0%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio8.92×

Celldex Therapeutics, Inc.

CLDXNASDAQ Capital Market·USD·Closed

Celldex Therapeutics, Inc.

CLDXNASDAQ·USD·Closed

$38.06

−1.10%

$38.06

−$0.42 (1.10%)

52W Range

89thpctl

Volume

0.88×avg

Mkt Cap

2.53BUSD

P/E

-8.9TTM

Div Yield

–ann

52W Range

89thpctl

Volume

0.88×avg

Market Cap

2.53BUSD

P/E Ratio

-8.9TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings